Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Raimundo Fernandes

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Scandinavian Journal of Gastroenterology|May 23, 2022
Proactive infliximab is more effective than vedolizumab in inducing fecal calprotectin remission in inflammatory bowel diseaseSamuel Raimundo Fernandes, Inês Coelho Rodrigues, Juliana Serrazina, et al.
Inflammatory Bowel Diseases|June 25, 2025
Early Top-Down Treatment With Biologics Improves the Rates of Transmural Remission in Crohn's Disease-A Risk-Adjusted Propensity Score Matched AnalysisSamuel Raimundo Fernandes, Inês Coelho Rodrigues, André Da Silva Neves, et al.
Revista Espanola De Enfermedades Digestivas|October 6, 2016
The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitisSamuel Raimundo Fernandes, Patrícia Santos, Carlos Miguel Moura, et al.
United European Gastroenterology Journal|December 28, 2022
Transmural remission improves clinical outcomes up to 5 years in Crohn's diseaseSamuel Raimundo Fernandes, Juliana Serrazina, Inês Ayala Botto, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 10, 2019
Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendationsAndrea Párniczky, Tamás Lantos, Eszter Margit Tóth, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Scandinavian Journal of Gastroenterology|May 23, 2022
Proactive infliximab is more effective than vedolizumab in inducing fecal calprotectin remission in inflammatory bowel diseaseSamuel Raimundo Fernandes, Inês Coelho Rodrigues, Juliana Serrazina, et al.
Inflammatory Bowel Diseases|June 25, 2025
Early Top-Down Treatment With Biologics Improves the Rates of Transmural Remission in Crohn's Disease-A Risk-Adjusted Propensity Score Matched AnalysisSamuel Raimundo Fernandes, Inês Coelho Rodrigues, André Da Silva Neves, et al.
Revista Espanola De Enfermedades Digestivas|October 6, 2016
The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitisSamuel Raimundo Fernandes, Patrícia Santos, Carlos Miguel Moura, et al.
United European Gastroenterology Journal|December 28, 2022
Transmural remission improves clinical outcomes up to 5 years in Crohn's diseaseSamuel Raimundo Fernandes, Juliana Serrazina, Inês Ayala Botto, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 10, 2019
Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendationsAndrea Párniczky, Tamás Lantos, Eszter Margit Tóth, et al.
Pageof 3